Pediatric cancer recurrence prediction is a vital area of research, as it can dramatically impact treatment outcomes for young patients battling conditions such as gliomas.Recent advancements in AI in pediatric oncology have led to more precise forecasting of relapse risk, surpassing traditional methods once regarded as the standard.